28 February 2025 in Pain Medicine
Objective: To evaluate current administrative coding practices for opioid misuse (OM) within the World Health Organization’s International Classification of Diseases (ICD) framework and develop standardized documentation recommendations. Design: Systematic scoping review following PRISMA-ScR guidelines. Setting: Analysis of studies using administrative databases, including electronic health records (EHRs), insurance claims, and national healthcare utilization databases. Subjects: Studies published in peer-reviewed journals examining administrative codes for OM, excluding those focused solely on illicit drugs, opioid use disorder (OUD), or using only natural language processing/qualitative methods. Methods: Comprehensive search of Embase, Medline, Google Scholar, and PubMed databases following PRISMA-S extension guidelines. Three independent reviewers screened articles and extracted data. Study quality was assessed using a modified Newcastle-Ottawa Scale. Results: Of 9561 initial records, 19 studies met inclusion criteria. The use of ICD-10 code F11.9* (Opioid use) emerged as the most referenced method for documenting OM, distinguishing it from OUD methods (F11.1, opioid abuse; F11.2, opioid dependence). Studies demonstrated significant heterogeneity in coding practices, resulting in code-based definitions identifying only approximately 50% of cases compared to more comprehensive clinical assessment approaches. Conclusions: While ICD-10 code F11.9* can effectively document OM as distinct from OUD, successful implementation requires consensus on the clinical definition of OM and documentation in the form of clear clinical guidelines and operationalized through enhanced EHR integration. Future research should focus on validating these approaches across diverse healthcare settings.
25 August 2025 in Pain Medicine
Objective: To systematically evaluate existing approaches for identifying opioid use disorder (OUD) in administrative data sets and develop evidence-based recommendations for standardized identification methods. Design: Systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Scoping Review guidelines with comprehensive literature search and evidence synthesis for framework development. Setting: Administrative data sets including commercial claims, Medicaid, Medicare, and electronic health records. Subjects: In brief, 169 studies using administrative codes to identify OUD, primarily from US healthcare systems (94.7%). Methods: Systematic search of EMBASE, MEDLINE, Google Scholar, and PubMed through February 2024. Three independent reviewers screened articles and extracted data using standardized tools. Study quality was assessed using modified Newcastle-Ottawa Scale. Framework development employed systematic integration of evidence-based components from high-quality studies. Results: Our analysis of 169 studies revealed four distinct identification approaches: Direct diagnosis codes (36.7%), composite definitions (48.0%), overdose codes (10.1%), and medication-assisted treatment codes (1.2%). Commercial claims data predominated (60.4%), followed by Medicaid claims (10.1%) and electronic health records (7.7%). Multi-modal strategies incorporating both diagnostic and treatment codes showing superior theoretical foundation compared to single-method approaches. Substantial variation existed in reference periods, code requirements, and treatment verification approaches. Conclusions: An evidence-based framework incorporating diagnosis codes, specific temporal requirements, validated indirect indicators, and treatment evidence provides theoretical foundation for standardized OUD identification protocols. The framework addresses known sources of misclassification while maintaining diagnostic specificity through clinical diagnostic alignment and systematic validation research programs. Registration: Prospero (CRD42023406173) and OSF (osf.io/ru4j3)